logo
Share SHARE
FONT-SIZE Plus   Neg

Correction: Bunge Q4 Profit Down - Quick Facts

correction: corrects last year's figure for net income to Bunge common shareholders in the first para.

Bunge Ltd. (BG) posted a decline in its fourth-quarter net income attributable to the company to $254 million from $301 million in the prior-year quarter, with net income to Bunge common shareholders dropping to $245 million from $292 million in the previous year.

Quarterly earnings per share were $1.65, a decrease from $1.95 in the earlier year quarter. Earnings per share, excluding certain gains & charges, amounted to $1.99 a year earlier. On average, 12 analysts polled by Thomson Reuters expected earnings per share of $1.57 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales for the three-month period were $16.44 billion, higher than last year's $12.73 billion, while eight analysts estimated revenues of $13.73 billion for the quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Foodservice distributor Sysco Corp. (SYY) reported a third-quarter profit that grew 22.7 percent from last year, while quarterly sales increased 2.2 percent. Both earnings per share and revenue for the quarter beat analysts' expectations. Halliburton Co. (HAL) and Baker Hughes Inc. (BHI) announced Sunday that they terminated the merger agreement they entered into in November 2014, effective April 30, 2016. In connection with the termination of the merger agreement, Halliburton will pay Baker Hughes the termination fee of $3.5 billion... The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves.
comments powered by Disqus
Follow RTT